TrialThe lancet. HIV2017

Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.

Renee Heffron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.